Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...
Hosted on MSN4d
Anthropic's Claude vulnerable to 'emotional manipulation'
AI model safety only goes so far Anthropic's Claude 3.5 Sonnet, despite its reputation as one of the better behaved ...
Sonnet Partners Alkem To Develop And Market SON-080 For Diabetic Peripheral Neuropathy In India
Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...
Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing ...
AV Network9d
What to Know About Sonnet's New Thunderbolt Adapter
Bus-powered Thunderbolt adapter connects two 4K 120Hz HDMI displays to a single thunderbolt or USB4 computer port.
Daily4d
Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
Roger Ebert1d
Criterion Adds Val Lewton Double Feature to the Collection
Lewton, who oversaw the RKO horror unit that churned out a series of esoteric, visually stunning, and sometimes ...
Topic: Claude 3.5 Sonnet
Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical ...
Gramophone1d
Video of the Day: Yunchan Lim performs Liszt's Petrarch Sonnet No 104 at the 2024 Gramophone Awards
A captivating live Liszt performance by Yunchan Lim, Gramophone's Young Artist of the Year and also winner of the Piano category at the 2024 Gramophone Awards ...